Hinge Health, Inc. Class A Common Stock (HNGE)
R&D Expenses
$34.06M
Quarterly · Period ending: · USD
HNGE R&D Expenses
Latest reported$34.06Mperiod ending
Latest reported$34.06Mperiod ending
HNGE Quarterly R&D Expenses ($27.80M → $34.06M)
Quarterly R&D Expenses
High-resolution chart · PNG
HNGE r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 34,057,000 | |
| 30,338,000 | |
| 32,755,000 | |
| 31,921,000 | |
| 279,962,000 | |
| 23,500,000 | |
| 22,371,000 | |
| 23,785,000 | |
| 24,920,000 | |
| 30,763,000 | |
| 28,578,000 | |
| 28,457,000 | |
| 27,800,000 |